LOGIN  |  REGISTER
Chimerix
Compass Therapeutics

AirSculpt® Technologies Announces Opening of Its Newest Location in Raleigh

September 18, 2023 | Last Trade: US$3.51 0.11 3.24

MIAMI BEACH, Fla., Sept. 18, 2023 (GLOBE NEWSWIRE) -- AirSculpt® Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS), an industry leader and provider of premium body contouring procedures, today announced the opening of its newest center in Raleigh, NC. The Raleigh location increases the company’s center count to 27 locations throughout the United States, Canada and the UK.

AirSculpt® is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt locations. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

“We are thrilled to bring AirSculpt to Raleigh,” said Todd Magazine, Chief Executive Officer at AirSculpt® Technologies. “Our Charlotte location has delivered great results for North Carolinians so we are pleased to be able to deliver more location choices for potential patients.”

The Raleigh location is conveniently located in a prime spot between downtown Raleigh and Durham. The new office is located at 8510 Colonnade Center Drive, Suite 100, Raleigh, NC and can be reached at (919) 391-3750.

More than 40,000 AirSculpt cases have been performed in AirSculpt’s premium locations throughout the U.S, Canada and the United Kingdom. For additional information about scheduling a virtual or in-person consultation at any of the 27 centers, visit airsculpt.com.

About AirSculpt®

AirSculpt® is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

Investor Contact:
Steven Halper/Caroline Paul
Managing Directors, LifeSci Advisors
This email address is being protected from spambots. You need JavaScript enabled to view it.

Media Contact:
Stephanie Evans Greene
Chief Marketing Officer
This email address is being protected from spambots. You need JavaScript enabled to view it.

Stock Quote

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page

COPYRIGHT ©2023 HEALTH STOCKS HUB